Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free

Top Stock Reports for Tesla, Bank of America & Coca-Cola

By Mark Vickery | September 24, 2026, 3:55 PM

Thursday, September 24, 2026

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Tesla, Inc. (TSLA), Bank of America Corp. (BAC) and The Coca-Cola Co. (KO), as well as a micro-cap stock: Texas Community Bancshares, Inc. (TCBS). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> Trump & Xi Meet While Oil & Bond Yields Rise

Today's Featured Research Reports

Shares of Tesla have underperformed the Zacks Automotive - Domestic industry over the past year (-10.2% vs. +3%). The company is entering a multi-year investment cycle, with sharply higher capital spending and negative free cash flow pressure. Automotive and energy margins weakened, regulatory credit revenue fell further, and newer platforms still face scaling and execution risk. 

Competition and lower vehicle pricing also limit visibility into durable earnings growth, while elevated spending raises the burden of execution. Therefore, the stock warrants a cautious stance.

Nevertheless, Tesla’s record second-quarter deliveries, rising FSD adoption and expanding energy storage operations support its longterm growth case. Cybercab production, broader Robotaxi coverage and new Optimus lines also extend the company’s software and robotics optionality. Services profitability and a large cash balance support the broader roadmap.

(You can read the full research report on Tesla here >>>)

Bank of America’s shares have gained +10.3% over the past year against the Zacks Financial - Investment Bank industry’s gain of +12.5%. The company’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters. Net interest income (NII) growth is expected to continue in the near term supported by steady loan growth amid a higher-for-longer rate environment. 

Bank of America’s expansion strategy by opening financial branches will boost the top line. Along with this, investments in digital capabilities will enhance client engagement and cross-selling opportunities, likely driving fee income. 

However, elevated expenses due to investments in technology and franchise expansion will likely hurt the bottom line to some extent. The volatile nature of the capital markets business makes growth in trading revenues uncertain. Weak asset quality is another concern, which might hamper financials.

(You can read the full research report on Bank of America here >>>)

Shares of Coca-Cola have outperformed the Zacks Beverages - Soft drinks industry over the past year (+37% vs. +24%). The company’s growth story is supported by its broad portfolio, global scale and disciplined execution. These strengths drive resilient growth, share gains and margin expansion. Innovation is central, with products, new formats and campaigns expanding consumption occasions and reinforcing brand relevance. 

Digital tools, advanced analytics and artificial intelligence are improving forecasting, pricing, customer engagement and bottling-system execution, supporting productivity and organic growth. The raised 2026 outlook reflects confidence in the company’s resilient model, operating leverage and long-term earnings potential. 

Still, uneven demand, pressure on lower-income consumers, affordability actions in Asia Pacific, currency swings, geopolitical volatility and the pending Africa bottling divestiture remain key risks.

(You can read the full research report on Coca-Cola here >>>)

Texas Community Bancshares’ shares have gained +5.5% over the past year against the Zacks Banks - Southeast industry’s gain of +6.3%. This microcap company with a market capitalization of $48.84 million has its investment case supported by improving core profitability, with margin expansion benefiting from disciplined loan and deposit pricing, stronger lending activity and a more favorable funding mix. 

Renewed loan growth is being supported by deposit expansion, while improving legacy credit trends and stronger earnings are helping capital build and supporting shareholder returns. However, risks remain. Elevated OREO continues to expose earnings and asset values to carrying costs and property-sale outcomes, while higher delinquencies and criticized loans warrant monitoring. 

Funding still carries some wholesale and rate sensitivity, and rising technology, processing and occupancy costs could pressure operating leverage if revenue growth slows. Overall, execution on credit cleanup, funding discipline and expense absorption remains key.


(You can read the full research report on Texas Community Bancshares here >>>)

Other noteworthy reports we are featuring today include Bristol-Myers Squibb Co. (BMY), Edison International (EIX) and Gartner, Inc. (IT).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Tesla (TSLA) Energy Business Aids While Heavy Capex Ails

Expansion Efforts, Loan Growth Aids Bank of America (BAC), Costs Ail

Coca-Cola (KO) Benefits From Global Scale and Brand Strength

Featured Reports

Investments Aid Edison International (EIX) Amid Wildfire Risks
Per the Zacks analyst, Edison International invests steadily to enhance infrastructure reliability. Yet wildfire risks in its service area lead to frequent damages and outages.

Gartner (IT) Gains From AI and Cybersecurity Advisory Demand
Per the Zacks analyst, Gartner's contract value growth should strengthen as enterprises seek guidance on AI, cybersecurity and other mission-critical priorities, reinforcing its long-term relevance.

Data Center Growth Aids Advanced Energy (AEIS) Prospects
Per the Zacks Analyst Advanced Energy benefits from strong demand in the data center computing market and customer adoption of its advanced semiconductor technologies like eVoS and eVerest platforms.

Banking Technology Demand Aids Jack Henry (JKHY) Prospects
Per the Zacks Analyst, Jack Henry and Associates is gaining from recurring processing, hosting and cloud demands as banks and credit unions modernize their fintech capabilities.

Axcelis (ACLS) Rides on Solid AI Traction and Recurring Revenue Growth
Per the Zacks analyst, demand recovery across memory, power and mature-node applications, combined with an expanding recurring revenue base, will likely support Axcelis topline.

FuelCell Energy (FCEL) Gains From Data Center Growth
The Zacks analyst believes that FuelCell Energy's data-center growth offers upside, but uncertain contract conversion and persistent losses temper the outlook.

Robust Control-IQ+ Demand Aids Tandem Diabetes (TNDM) Amid Rival Woes
The Zacks Analyst is impressed with Tandem Diabetes enjoying competitive edge with Control-IQ+, the only FDA-cleared, AID technology for use during pregnancy. Competitive pressures may curb growth.

New Upgrades

Solid Key Drugs' Demand, Pipeline Progress Fuel Bristol Myers (BMY)
Per the Zacks analyst, strong demand of key drugs has enabled Bristol Myers to offset the impact of generic erosion of legacy drugs. Recent drug approvals is broadening commercial opportunities.

Increase in New Insurance Written Aid MGIC Investment (MTG)
Per the Zacks analyst, MGIC Investment is poised to grow on higher insurance in force, improved direct premium yield, higher annual persistency, lower claims and a strong capital position.

Leasing Momentum & Rent Growth Aid SL Green's (SLG) Performance
Per the Zacks analyst, SL Green benefits from strong Manhattan leasing momentum, scarce premium space and rising replacement rents. Higher occupancy and One Vanderbilt contributions support growth.

New Downgrades

Pilgrim's Pride (PPC) Faces Margin Woes Due to Challenges in Europe
Per the Zacks analyst, Pilgrim's Pride is likely to face margin pressure as intense European competition and pork imports weigh on pricing and profitability.

Rising Expenses & Volatile Cash Flow Weigh on AMERISAFE (AMSF)
Per the Zacks analyst, AMERISAFE's rising expenses are likely to pressure its profitability. Also, volatile cash flow could weigh on its financial flexibility and overall performance.

Yum! Brands (YUM) Faces Sales, Execution and Margin Headwinds
Per the Zacks analyst, consumer pressure, Pizza Hut weakness and brand challenges could weigh on Yum! Brands, while modest KFC comps and Taco Bell's recovery may limit sales growth.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Bank of America Corporation (BAC): Free Stock Analysis Report
 
CocaCola Company (The) (KO): Free Stock Analysis Report
 
Tesla, Inc. (TSLA): Free Stock Analysis Report
 
Texas Community Bancshares, Inc. (TCBS): Free Stock Analysis Report
 
Bristol Myers Squibb Company (BMY): Free Stock Analysis Report
 
Edison International (EIX): Free Stock Analysis Report
 
Gartner, Inc. (IT): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News

1 hour
2 hours
3 hours
3 hours
4 hours
4 hours
4 hours
5 hours
5 hours
6 hours
6 hours
6 hours
6 hours
7 hours
7 hours